Pfizer Inc. (NYSE:PFE) is one of the stocks Jim Cramer recently shed light on. Cramer highlighted some of the stock’s possible catalysts, as he commented: “All right, next up, controversial, it’s ...

Bayer has filed separate lawsuits against the creators of three COVID-19 vaccines, claiming they violated intellectual ...

Pfizer has demonstrated remarkable financial resilience in its latest quarterly report, significantly outpacing Wall Street expectations across key metrics. The pharmaceutical powerhouse announced ...

Bank of America (BofA) Securities updated the earnings model for Pfizer Inc. (NYSE:PFE). The company will announce second-quarter 2025 earnings on August 5. According to data from Benzinga Pro, ...

Pfizer is one of the largest pharmaceutical companies on the planet. It has a proven track record of finding, developing, and commercializing new drugs. The recent price advance is worth paying ...

Pfizer sued Novo Nordisk, Metsera and Metsera's controlling shareholders on Oct. 31 in Delaware Court of Chancery in relation to Pfizer's proposed acquisition of Metsera, an obesity treatment maker.

Pfizer Inc. (NYSE: PFE) is scheduled to provide its full-year 2026 financial guidance on Tuesday, with Bank of America Securities expecting the company's growth profile to closely resemble conditions ...

Pfizer's Q3 earnings fell, but the company still raised its full-year earnings guidance. Major cost reductions remain on track, which should significantly boost the drugmaker's bottom line. Pfizer's ...

Pfizer is a Buy for medium- to long-term investors, trading at a low P/E and undervalued versus peers, with strong non-COVID growth. Strategic pivots include aggressive R&D, cost-cutting, and the ...

Orient Pharma was hit with a patent infringement lawsuit on June 16 in Delaware District Court over its attempt to market generic versions of Pfizer's Xeljanz XR treatment for autoimmune conditions.

(Bloomberg) -- A judge denied Pfizer Inc.’s request to temporarily block Novo Nordisk A/S’ $10 billion bid to acquire the obesity startup Metsera Inc., saying the US pharmaceutical company’s ...

Key takeaways from Supreme Court arguments on Nov. 5 over the legality of the Trump administration’s reciprocal and fentanyl-linked tariffs led Bloomberg Intelligence’s Votes and Verdicts podcast this ...